Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03230110 · ClinicalTrials.gov registry record

OSA in Pregnant Women With Chronic HTN

A clinical trial, sponsored by Duke University.

Completed
Registry status
100
Enrollment target

NCT03230110: Completed study, sponsored by Duke University.

NCT03230110 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03230110 has completed, sponsored by Duke University.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

The purpose of this study is to identify whether pregnant women with chronic hypertension are at significantly higher risk of having undiagnosed OSA and should be routinely screened with home sleep tests. The investigators will recruit 120 pregnant subjects between 10-20 weeks gestation from the Duke High Risk Obstetrics Clinic over a 20-month period. They will be enrolled into one of two groups: 1) chronic hypertension (on medication or hypertensive blood pressures documented at 3 clinic visits); 2) normal blood pressure, and not on any treatment for chronic HTN and no history of chronic HTN, and matched for BMI (+/- 3 kg/m2) with the chronic HTN group. The two groups will be matched for BMI to control for the effect of obesity on OSA diagnosis and cHTN. The primary hypothesis, that OSA prevalence differs between patients with chronic HTN and normotensive controls, will be assessed with a two-group two-sided Fisher's exact test. A Fisher's exact test with a 0.05 two-sided significance level will have 92% power to detect the difference between a normotensive OSA rate of 0.10 and a chronic hypertensive OSA rate of 0.40 when the sample size in each group is 50. There are no risks associated with the use of the home sleep test device, but subjects that have a severe latex allergy should not participate, as the device

Interventions

  • DIAGNOSTIC_TEST WP200U home sleep study device

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2017-06-16
Est. Completion 2019-04-30
Duke University

1,725 total trials

What the finished NCT03230110 record still lists

NCT03230110 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which WP200U home sleep study device is the first listed.

NCT03230110 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03230110 about?

NCT03230110 is a clinical study titled "OSA in Pregnant Women With Chronic HTN". The purpose of this study is to identify whether pregnant women with chronic hypertension are at significantly higher risk of having undiagnosed OSA and should be routinely screened with home sleep tests. The investigators will recruit 120 pregnant subjects between 10-20 weeks gestation from the Duk...

What is the current status of trial NCT03230110?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-06-16. Estimated completion is 2019-04-30.

What interventions are being tested in trial NCT03230110?

The interventions under investigation include: WP200U home sleep study device (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03230110?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03230110, the US trial registry maintained by the National Library of Medicine. NCT03230110 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.